Volume 5; Issue 2

Inflammatory Bowel Diseases

Volume 5; Issue 2
1

Masthead

Year:
1999
Language:
english
File:
PDF, 58 KB
english, 1999
8

Adapter molecules in T cell receptor signaling

Year:
1999
Language:
english
File:
PDF, 1.24 MB
english, 1999
10

Patient compliance and outcomes

Year:
1999
Language:
english
File:
PDF, 453 KB
english, 1999
14

Clinical pearls from the 1998 FMAC/CMAC meeting

Year:
1999
Language:
english
File:
PDF, 189 KB
english, 1999
15

Aberrant mucosal cytokines: The key to the pathogenesis of IBD?

Year:
1999
Language:
english
File:
PDF, 251 KB
english, 1999
16

Mephitic muchness in colitis: A “future therapy” target?

Year:
1999
Language:
english
File:
PDF, 138 KB
english, 1999
17

Will the real 5-aminosalicylic acid please stand up?

Year:
1999
Language:
english
File:
PDF, 270 KB
english, 1999
18

Mesalamine: Safe at first look

Year:
1999
Language:
english
File:
PDF, 234 KB
english, 1999
20

Patient Compliance and Outcomes

Year:
1999
Language:
english
File:
PDF, 453 KB
english, 1999
21

MEPHITIC MUCHNESS IN COLITIS: A “FUTURE THERAPY” TARGET?

Year:
1999
Language:
english
File:
PDF, 138 KB
english, 1999
23

MESALAMINE: SAFE AT FIRST LOOK

Year:
1999
Language:
english
File:
PDF, 234 KB
english, 1999
27

ABERRANT MUCOSAL CYTOKINES: THE KEY TO THE PATHOGENESIS OF IBD?

Year:
1999
Language:
english
File:
PDF, 251 KB
english, 1999
31

Adapter Molecules in T Cell Receptor Signaling

Year:
1999
Language:
english
File:
PDF, 1.24 MB
english, 1999
34

Usefulness of Crohnʼs Disease Activity Index in Medicine

Year:
1999
Language:
english
File:
PDF, 215 KB
english, 1999
35

Clinical Pearls from the 1998 FMAC/CMAC Meeting

Year:
1999
Language:
english
File:
PDF, 189 KB
english, 1999
36

WILL THE REAL 5-AMINOSALICYLIC ACID PLEASE STAND UP?

Year:
1999
Language:
english
File:
PDF, 270 KB
english, 1999